Blackcrane Capital’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $3.15M | Sell |
30,201
-937
| -3% | -$97.7K | 19.29% | 2 |
|
|
2021
Q4 | $3.75M | Buy |
31,138
+2,860
| +10% | +$344K | 5.2% | 7 |
|
|
2021
Q3 | $3.16M | Buy |
28,278
+6,809
| +32% | +$760K | 4.02% | 7 |
|
|
2021
Q2 | $2.58M | Buy |
21,469
+6,898
| +47% | +$829K | 3.15% | 11 |
|
|
2021
Q1 | $1.72M | Sell |
14,571
-20,665
| -59% | -$2.44M | 2.72% | 10 |
|
|
2020
Q4 | $641K | Buy |
35,236
+9,513
| +37% | +$173K | 1.26% | 11 |
|
|
2020
Q3 | $459K | Hold |
25,723
| – | – | 1.07% | 8 |
|
|
2020
Q2 | $461K | Sell |
25,723
-109,734
| -81% | -$1.97M | 0.52% | 9 |
|
|
2020
Q1 | $2.06M | Sell |
135,457
-37,251
| -22% | -$565K | 1.88% | 9 |
|
|
2019
Q4 | $3.41M | Hold |
172,708
| – | – | 2.72% | 9 |
|
|
2019
Q3 | $2.97M | Sell |
172,708
-247
| -0.1% | -$4.25K | 3.95% | 9 |
|
|
2019
Q2 | $3.06M | Sell |
172,955
-16,594
| -9% | -$294K | 3.88% | 9 |
|
|
2019
Q1 | $3.86M | Buy |
+189,549
| New | +$3.86M | 5.16% | 8 |
|